Richard A Brown1,2, Jacki Hecht1,2, Erika L Bloom1,2, Haruka Minami1,2, Christopher W Kahler3, Ana M Abrantes1,2, Mary E Dubreuil1,2, Alan Gordon1,2, Lawrence H Price1,2, Steven J Ondersma4. 1. Butler Hospital, Providence, Rhode Island. 2. Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, Providence, Rhode Island. 3. Center for Alcohol and Addiction Studies and the Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, Rhode Island. 4. Merrill-Palmer Skillman Institute and Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, Michigan.
Abstract
BACKGROUND AND OBJECTIVES: The majority of individuals in substance use disorder (SUD) treatment also smoke cigarettes; yet, the availability of smoking cessation services in SUD treatment remains limited. In this study, we developed and piloted a brief intervention for smokers in SUD treatment intended to motivate engagement in tobacco quitline treatment (TIME-TQ). METHODS: First, we interviewed 19 smokers in SUD treatment to inform the development of TIME-TQ (Phase 1). Second, we delivered a prototype TIME-TQ to 16 smokers in the same SUD treatment program and followed them for 3 months post-discharge (Phase 2). RESULTS: Feedback from Phase 1 participants was used to refine response choices and video segments included in the prototype TIME-TQ. Phase 2 participants rated TIME-TQ high on relevance, interest, respectfulness, and helpfulness. Additionally, they reported significant increases in readiness to quit and perceived importance of quitting after receiving TIME-TQ. A total of 8 of the 16 accepted a quitline referral, and 8 of 13 reached for follow-up (four referral acceptors, four decliners) reported efforts to quit or reduce smoking during the follow-up period. However, only three received quitline counseling and none achieved a sustained period of abstinence. CONCLUSIONS AND SCIENTIFIC SIGNIFICANCE: Our results suggest that TIME-TQ activated these patients to quit smoking, but our referral method (standard fax referral) was unsuccessful in helping participants fully engage in quitline treatment or achieving a period of abstinence. SCIENTIFIC SIGNIFICANCE: We are now conducting an RCT to evaluate TIME-TQ with a revised referral procedure intended to increase treatment engagement and, ultimately, abstinence rates. (Am J Addict 2017;26:587-594).
BACKGROUND AND OBJECTIVES: The majority of individuals in substance use disorder (SUD) treatment also smoke cigarettes; yet, the availability of smoking cessation services in SUD treatment remains limited. In this study, we developed and piloted a brief intervention for smokers in SUD treatment intended to motivate engagement in tobacco quitline treatment (TIME-TQ). METHODS: First, we interviewed 19 smokers in SUD treatment to inform the development of TIME-TQ (Phase 1). Second, we delivered a prototype TIME-TQ to 16 smokers in the same SUD treatment program and followed them for 3 months post-discharge (Phase 2). RESULTS: Feedback from Phase 1 participants was used to refine response choices and video segments included in the prototype TIME-TQ. Phase 2 participants rated TIME-TQ high on relevance, interest, respectfulness, and helpfulness. Additionally, they reported significant increases in readiness to quit and perceived importance of quitting after receiving TIME-TQ. A total of 8 of the 16 accepted a quitline referral, and 8 of 13 reached for follow-up (four referral acceptors, four decliners) reported efforts to quit or reduce smoking during the follow-up period. However, only three received quitline counseling and none achieved a sustained period of abstinence. CONCLUSIONS AND SCIENTIFIC SIGNIFICANCE: Our results suggest that TIME-TQ activated these patients to quit smoking, but our referral method (standard fax referral) was unsuccessful in helping participants fully engage in quitline treatment or achieving a period of abstinence. SCIENTIFIC SIGNIFICANCE: We are now conducting an RCT to evaluate TIME-TQ with a revised referral procedure intended to increase treatment engagement and, ultimately, abstinence rates. (Am J Addict 2017;26:587-594).
Authors: Dennis Moore; Marietta Langlois; Bridget M Gerber; Ray Gaddis; Jeffrey S Hallam; Rudy Arnold Journal: Subst Use Misuse Date: 2007 Impact factor: 2.164
Authors: Joseph Guydish; Emma Passalacqua; Barbara Tajima; Mable Chan; Jongserl Chun; Alan Bostrom Journal: Nicotine Tob Res Date: 2011-04-04 Impact factor: 4.244
Authors: Paul McCrone; Martin Knapp; Judith Proudfoot; Clash Ryden; Kate Cavanagh; David A Shapiro; Sophie Ilson; Jeffrey A Gray; David Goldberg; Anthony Mann; Isaac Marks; Brian Everitt; Andre Tylee Journal: Br J Psychiatry Date: 2004-07 Impact factor: 9.319
Authors: Gary J Tedeschi; Sharon E Cummins; Christopher M Anderson; Robert M Anthenelli; Yue-Lin Zhuang; Shu-Hong Zhu Journal: PLoS One Date: 2016-07-08 Impact factor: 3.240
Authors: Ewelina Smoktunowicz; Azy Barak; Gerhard Andersson; Rosa M Banos; Thomas Berger; Cristina Botella; Blake F Dear; Tara Donker; David D Ebert; Heather Hadjistavropoulos; David C Hodgins; Viktor Kaldo; David C Mohr; Tine Nordgreen; Mark B Powers; Heleen Riper; Lee M Ritterband; Alexander Rozental; Stephen M Schueller; Nickolai Titov; Cornelia Weise; Per Carlbring Journal: Internet Interv Date: 2020-06-02
Authors: Gabriela Marcu; Steven J Ondersma; Allison N Spiller; Brianna M Broderick; Reema Kadri; Lorraine R Buis Journal: J Med Internet Res Date: 2022-03-30 Impact factor: 5.428